Dizal Announces Clinical Results of Golidocitinib Published in Annals of Oncology ...Middle East

SHANGHAI, Sept. 10, 2023 /PRNewswire/ -- Dizal today announced the publication of the Phase I clinical data of golidocitinib for the treatment of relapsed or refractory (r/r) peripheral T cell lymphomas (PTCL) (JACKPOT8 PARTA) in Annals of Oncology (2022-2023 Impact Factor: 51.8). PTCL is...

Hence then, the article about dizal announces clinical results of golidocitinib published in annals of oncology was published today ( Sunday 10/09/2023 - 12:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dizal Announces Clinical Results of Golidocitinib Published in Annals of Oncology )

Also on site :

• Trader Joe's $4 Find Has Returned — Why Fans Obsess Over the Easy Dinner
• Brewers Acquire Junior Fernández
• Amazon’s 'Buttery-Soft' $7 Long-Sleeve Shirt Is a 'Staple Piece' That Has Shoppers Running Back for More